| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 107 |
| 1 | INFLIXIMAB | 89 |
| 2 | METHOTREXATE SODIUM | 81 |
| 3 | METHOTREXATE | 76 |
| 4 | ADALIMUMAB | 68 |
| 5 | MYCOPHENOLATE MOFETIL | 66 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 66 |
| 7 | TACROLIMUS | 54 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 54 |
| 9 | TACROLIMUS OINTMENT 0.1% | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPIRIN AND DIPYRIDAMOLE | 1 | 0.0042 |
| 1 | INFLUENZA A VIRUS, INFLUENZA B VIRUS, HISTAMINUM HYDROCHLORICUM, ACONITUM NAP., ARALIA QUINQUEFOLIA, ARSENICUM ALB., BAPTISIA, BRYONIA, CINCHONA, EUPATORIUM PERF., GELSEMIUM, IPECAC., KALI CARB., NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, ECHINACEA | 1 | 0.0029 |
| 2 | ZANAMIVIR | 6 | 0.0024 |
| 3 | BARICITINIB | 6 | 0.0020 |
| 4 | HYALURONIC ACID | 2 | 0.0017 |
| 5 | SORBITOL | 1 | 0.0017 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 12 | 0.0014 |
| 7 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 8 | ALEMTUZUMAB | 20 | 0.0010 |
| 9 | METYRAPONE | 1 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neuraminidase Inhibitor [EPC] | 6 | 0.0024 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 20 | 0.0010 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 4 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0004 |
| 8 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |